The use of direct oral anticoagulants (DOACs) was associated with a reduction in dementia risk compared to traditional blood thinners—like warfarin—in atrial fibrillation patients, particularly in Asian patients. According ...
Sep 5, 2023
0
2
Modern blood-thinning drugs (known as NOACs) reduce the risk of serious bleeding by up to 45% compared to the traditional drug Waran (warfarin) in the treatment of blood clots in the legs and lungs. All according to a comprehensive ...
Aug 29, 2023
0
0
For patients with venous thromboembolism (VTE) continuing warfarin or direct oral anticoagulants (DOACs) beyond six months, the risk for recurrent VTE is lower with DOACs, according to a study published online Aug. 15 in ...
Aug 21, 2023
0
0
Patients with atrial fibrillation usually receive blood thinners to reduce their stroke risk, but these drugs are under-prescribed to Black Americans, a new study reveals.
May 3, 2022
0
3
Researchers at the National Cerebral and Cardiovascular Center in Japan found that patients aged ≥75 years with non-valvular atrial fibrillation (NVAF) and previous stroke/transient ischemic attack (TIA) more commonly had ...
Apr 21, 2022
0
8
In a clinical practice guideline issued jointly by the American College of Gastroenterology and the Canadian Association of Gastroenterology and published online March 17 in the American Journal of Gastroenterology, updated ...
Mar 28, 2022
0
3
Direct oral anti-coagulant (anti-clotting) (DOAC) medications that target a single clotting factor work just as well to prevent future clots as the older, less-specific medication warfarin. DOACs are also less likely to result ...
Feb 10, 2022
0
30
Patients with atrial fibrillation are at risk of forming clots that can migrate to the brain and cause dangerous strokes; these can be prevented by chronic administration of blood-thinning drugs (anticoagulants). Introduced ...
Dec 20, 2021
0
4
The anticoagulant edoxaban may be just as effective as warfarin for preventing heart attack or stroke in patients with atrial fibrillation (AF) who undergo transcatheter aortic valve replacement (TAVR), according to a large-scale ...
Aug 28, 2021
0
84
(HealthDay)—For older adults with atrial fibrillation, apixaban is associated with lower rates of adverse events than warfarin across all frailty levels, according to a study published online July 20 in the Annals of Internal ...
Jul 20, 2021
0
4
